KTP (green light) laser for the treatment of benign prostatic hyperplasia. Preliminary evaluation

被引:3
|
作者
Coz, Fernando [1 ]
Domenech, Alfredo [1 ]
机构
[1] Hosp Militard Santiago, Serv Urol, Santiago, Chile
来源
PROGRES EN UROLOGIE | 2007年 / 17卷 / 05期
关键词
prostate; BPH; laser;
D O I
10.1016/S1166-7087(07)92395-7
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction : Photoselective vaporization of benign prostatic hyperplasia (BPH) is a minimally invasive technique, consisting of vaporization of prostatic tissue by KTP green light laser with a power of 80 W. The purpose of this study was to describe our experience with this technique. Material and method : KTP laser photoselective vaporization was per,formed in 18 patients, with lower obstructive uropathy secondary to benign prostatic hyperplasia at Santiago Military hospital from December 2005. Preoperative characteristics, postoperative results and complications were recorded. Results : Mean prostatic volume was 55 cc (range: 24 to 78). Mean operating time was 83 minutes (range: 40 to 120). In sixteen patients, the Foley catherer was removed before 24 hours. The mean preoperative AUA score was 22 and decreased to 11.4 after 30 days. The mean maximum preoperative urine flow rate was 9 ml/s and increased to 18.2; 22. 1; 22.5; 25.3 and 2 7.2 ml/s on days 1, 7, 14, 21 and 30, respectively. Only minor complications were observed: delayed removal of the Foley catheter (11.1%), dysuria (16.6%) and late haematuria (11.1%). Conclusion : KTP laser photoselective vaporization of BPH is a safe technique, that is easy to learn, with good short-term functional results, associated with a low complication rate.
引用
收藏
页码:950 / 953
页数:4
相关论文
共 50 条
  • [1] KTP laser photovaporization for the treatment of benign prostatic hyperplasia. A personal experience
    Fourcade, Richard Olivier
    [J]. E-MEMOIRES DE L ACADEMIE NATIONALE DE CHIRURGIE, 2010, 9 (01): : 32 - 35
  • [2] Green light laser (KTP, 80 W) for the treatment of benign prostatic hyperplasia
    Skriapas, K.
    Hellwig, W.
    Samarinas, M.
    Witzsch, U.
    Becht, E.
    [J]. MINERVA UROLOGICA E NEFROLOGICA, 2010, 62 (02) : 151 - 156
  • [3] Update on the treatment of benign prostatic hyperplasia.
    Douglass, MA
    Lin, JC
    [J]. FORMULARY, 2005, 40 (02) : 50 - +
  • [4] Interstitial laser coagulation for benign prostatic hyperplasia.
    Muschter, R
    Hofstetter, A
    [J]. ANNALES D UROLOGIE, 1997, 31 (01) : 27 - 37
  • [5] Benign prostatic hyperplasia.
    Bruskewitz, R
    [J]. JOURNAL OF UROLOGY, 1997, 158 (01): : 100 - 101
  • [6] Phytotherapeutic agents in the treatment of benign prostatic hyperplasia.
    Dreikorn K.
    [J]. Current Urology Reports, 2000, 1 (2) : 103 - 109
  • [7] Interstitial laser coagulation for benign prostatic hyperplasia. Commentary
    Auvert, J
    [J]. ANNALES D UROLOGIE, 1997, 31 (01) : 36 - 36
  • [8] GreenLight laser vaporisation of the prostate for treatment of benign prostatic hyperplasia. Development and significance
    Seifert, H. -H.
    Hermanns, T.
    Sulser, T.
    [J]. UROLOGE, 2008, 47 (08): : 964 - +
  • [9] Botulinum toxin in the treatment of benign prostatic hyperplasia. An overview
    Boy, S.
    Seif, C.
    Braun, P. M.
    Juenemann, K. -P.
    [J]. UROLOGE, 2008, 47 (11): : 1465 - 1471
  • [10] Benign prostatic hyperplasia. Prostate cancer
    Masson-Lecomte, A.
    [J]. PROGRES EN UROLOGIE, 2012, 22 (02): : F63 - F68